Published in Circulation on January 02, 2001
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart (2007) 1.90
Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int J Epidemiol (2008) 1.80
Timing and number of minor infections as risk factors for childhood arterial ischemic stroke. Neurology (2014) 1.62
Pneumococcal vaccination and risk of myocardial infarction. CMAJ (2008) 1.61
Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Med (Hagerstown) (2009) 1.57
Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis (2001) 1.11
Influenza virus infection and risk of acute myocardial infarction. Inflammation (2008) 1.07
Inflammatory mechanisms of stroke. Stroke (2010) 1.06
Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis (2011) 1.00
Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX. BMC Res Notes (2011) 0.99
Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol (2004) 0.95
Persistent endothelial activation and inflammation after Plasmodium falciparum Infection in Malawian children. J Infect Dis (2013) 0.91
Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine (Lond) (2009) 0.90
Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics. Biodemography Soc Biol (2009) 0.90
Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect Disord Drug Targets (2010) 0.89
Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol (2005) 0.88
Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus. Comp Med (2008) 0.87
Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun (2008) 0.87
Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One (2013) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
Pathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin. Exp Clin Cardiol (2012) 0.84
In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression. Cell Stress Chaperones (2008) 0.83
Detection of herplex simplex virus-1 and -2 in cardiac myxomas. J Biomed Biotechnol (2012) 0.82
Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart (2002) 0.82
Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr (2012) 0.81
Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis. Clin Diagn Lab Immunol (2002) 0.81
Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart (2005) 0.81
Platelet response as a sentinel marker of toll-like receptor 4 activation in mice. Thromb Res (2009) 0.80
Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study. Immun Ageing (2013) 0.80
Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome. J Am Heart Assoc (2016) 0.78
Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study. BMC Cardiovasc Disord (2006) 0.77
Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health (2016) 0.76
Childhood hospitalisation with infection and cardiovascular disease in early-mid adulthood: a longitudinal population-based study. PLoS One (2015) 0.76
Early cardiac allograft vasculopathy: are the viruses to blame? Case Rep Med (2012) 0.75
Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by Chlamydia. Braz J Med Biol Res (2016) 0.75
Cytomegalovirus in Plasma of Acute Coronary Syndrome Patients. Acta Naturae (2016) 0.75
Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study. Eur J Cardiovasc Nurs (2013) 0.75
Detection of human cytomegalovirus and epstein-barr virus in coronary atherosclerotic tissue. Braz J Microbiol (2010) 0.75
Infection with cytomegalovirus is not associated with premature mortality. Infect Dis Rep (2011) 0.75
Neighborhood of residence and incidence of coronary heart disease. N Engl J Med (2001) 15.16
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29
The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55
Neighborhood environments and coronary heart disease: a multilevel analysis. Am J Epidemiol (1997) 7.36
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA (1998) 5.80
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med (2000) 5.11
Neighbourhood differences in diet: the Atherosclerosis Risk in Communities (ARIC) Study. J Epidemiol Community Health (1999) 5.07
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol (2001) 3.99
Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95
Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med (1991) 3.80
Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol (2000) 3.71
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation (1973) 3.31
Colitis cystica profunda. Am J Clin Pathol (1966) 3.28
Reliability of scoring respiratory disturbance indices and sleep staging. Sleep (1998) 3.14
Sudden death in young athletes. Circulation (1980) 3.05
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (1998) 2.88
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol (1991) 2.85
A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med (1983) 2.85
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med (1999) 2.72
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med (1984) 2.71
Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med (1999) 2.69
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol (2000) 2.61
The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep (2001) 2.59
Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol (2001) 2.57
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol (1988) 2.53
Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol (2001) 2.51
An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol (1996) 2.46
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Restricted transport in small pores. A model for steric exclusion and hindered particle motion. Biophys J (1974) 2.42
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis (1988) 2.42
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA (1993) 2.25
HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation (1991) 2.22
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol (2001) 2.21
Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J (1990) 2.14
Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (1997) 2.11
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation (1976) 2.08
Mechanism of osmotic flow in porous membranes. Biophys J (1974) 2.07
The Bell Curve: on race, social class, and epidemiologic research. Am J Epidemiol (1996) 2.06
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (1999) 2.01
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation (1994) 1.98
Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.96
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Standardized full-field electroretinography. Normal values and their variation with age. Arch Ophthalmol (1992) 1.92
Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res (2001) 1.89
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1993) 1.89
Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation (1991) 1.88
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation (1998) 1.86
Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol (2000) 1.85
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med (1966) 1.83
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology (1999) 1.80
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1979) 1.80
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation (2000) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J (1998) 1.68
Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension (2001) 1.68
Social inequalities and atherosclerosis. The atherosclerosis risk in communities study. Am J Epidemiol (1995) 1.68
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis (2000) 1.66